Biocell Natural Killer Mixture in Diffuse Large B Cell Lymphoma (DLBCL) Patients

Clinical trial NCT00846157 · UNKNOWN

Trial details

NCT number: NCT00846157
Sponsor: NKBio Co.Ltd.
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Diffuse Large B-cell Lymphoma

Start date: 2007-09-01
Primary completion: 2011-09-01
Enrollment: 276

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.